The Cambridge Crystallographic Data Centre
Trustees’ report and financial statements for the year ending 31st December 2025
Table of Contents
About the Cambridge Crystallographic Data Centre (CCDC) and its purpose ........................................ 4
We shape the future of structural science: ........................................................................................................................................ 4 What we do .................................................................................................................................................................................................................. 4 What makes us different? ............................................................................................................................................................................... 5 Supporting the community ........................................................................................................................................................................... 5 Our strategy: advancing structural chemistry worldwide .................................................................................................... 6 Our strategic aims, vision, and mission ................................................................................................................................................ 7 Our values...................................................................................................................................................................................................................... 7 Public benefits ........................................................................................................................................................................................................... 8 Delivering our vision ................................................................................................................................................................ 8 Scientific innovation ............................................................................................................................................................................................12 Impact of the CCDC in worldwide research .................................................................................................................................... 13 CCDC Studentships ............................................................................................................................................................................................. 14 Key product releases ............................................................................................................................................................. 15 New database format ......................................................................................................................................................................................... 15 Covalent docking ................................................................................................................................................................................................... 15 CSD-Frameworks .................................................................................................................................................................................................. 16 PXRD matching and optimisation ......................................................................................................................................................... 16 Force field optimisation and interaction networks .................................................................................................................. 16 Structure validation ............................................................................................................................................................................................. 16 Looking forward ..................................................................................................................................................................................................... 17 Financial review ........................................................................................................................................................................ 18 Principal funding ................................................................................................................................................................................................... 18 Expenditure .............................................................................................................................................................................................................. 20 Investment policy ..................................................................................................................................................................................................21 Reserves ........................................................................................................................................................................................................................23 Structure, management, and governance ................................................................................................................ 24 Governance ............................................................................................................................................................................................................... 24 Nomination Committee ..................................................................................................................................................................................25 Audit Committee ..................................................................................................................................................................................................25 Remuneration Committee ............................................................................................................................................................................25 Risk Committee ..................................................................................................................................................................................................... 26 Management and staffing ............................................................................................................................................................................ 26 Remuneration policy ......................................................................................................................................................................................... 27 Risk management ............................................................................................................................................................................................... 27 Going concern ........................................................................................................................................................................................................ 28 Looking into the future ....................................................................................................................................................... 29
Reference and administrative details of the Charity, its trustees and advisers ................................... 30
2
Statement of trustees’ responsibilities ……………………………………………………………………………………..……………………………………..32 Independent auditor’s report …………………………………………………………………………………………………………………………..……...33 Consolidated statement of financial activities ………………………………………………………………………………….………….….37 Consolidated balance sheet ………………………………………………………………………………………………………………………………….…39 Charity balance sheet ………………………………………………………………………………………………………………………………………………..40 Consolidated statement of cash flows ………………………………………………………………………………………………………………..42 Notes to the financial statements …………………………………………………………………………………………………………………………43
Trustees’ report and financial statements for year ending 31 December 2025
The Trustees present their annual report together with the audited financial statements of the group and the company for the year 1 January 2025 to 31 December 2025. The Annual Report serves the purpose of both a Trustees’ report and a Directors’ report under company law. The Trustees confirm that the Annual Report and financial statements of the company comply with the current statutory requirements: the requirements of the company’s governing document and the provisions of the Statement of Recommended Practice (SORP) applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).
CSD Entry TABLAO – a potential platform for molecular solar thermal (MOST) energy conversion, storage, and release, added to the database in 2025.
3
About the Cambridge Crystallographic Data Centre (CCDC) and its purpose
We shape the future of structural science:
-
With scientific software, high-quality data, and professional services that accelerate the discovery and development of new medicines, chemical products, and advanced/functional materials.
-
By promoting collaboration across academia and industry globally to generate new discoveries and methods in structural science.
-
By inspiring and training a new generation of structural scientists worldwide through outreach and education.
What we do
CCDC are world-leading experts in high-quality structural chemistry data and scientific software, which generate knowledge and insights for scientific research and development. Our outputs support the discovery and development of new pharmaceuticals, functional materials, and fundamental chemistry, in industry and academia.
We specialise in the collation, curation, preservation, dissemination and application of chemical structural data for use in biopharmaceutical discovery and manufacturing, materials development, and research and education.
We compile and distribute the Cambridge Structural Database (CSD), a certified, trusted database of fully curated and enhanced organic and metal-organic experimental crystal structures, used by researchers across the globe. Our cutting-edge scientific software empowers scientists and researchers to extract invaluable insights and knowledge from this vast dataset, driving new innovations and discoveries.
CSD Entry SADZEH – a hydrated form of elafibranor, added to the database in 2025. Elafibranor is a dual PPARα/δ-agonist drug used in the treatment of primary biliary cholangitis.
4
What makes us different?
High-quality, trusted data
Each chemical structure in the CSD undergoes extensive validation and cross-checking via automated workflows (utilising machine learning techniques and semantic rules) and through manual curation by our expert chemists, crystallographers, and data analysts. This means users can trust that the data in the CSD is accurate, consistent, and of the highest quality.
Furthermore, we enrich the data with bibliographic, chemical, and physical property information and a range of additional metadata. This adds further value and scope to the original structural data and enables scientists and machines to interpret the structures in a chemically meaningful way.
Managing this data so that it is both available and secure is a critical part of how the CCDC ensures the CSD remains an important global data repository. We continue to invest in multiple layers of cyber-security, work with third parties to test our systems and software for vulnerabilities and run ongoing cyber-security training with all staff.
Unique data
We enable researchers to publish small molecule experimental crystallographic data that otherwise would have remained unpublished and unknown, directly through the CSD. The CSD therefore contains data that isn’t available anywhere else in the world.
Intelligent software and expertise
Our in-house software experts keep up to date with the latest developments in global data and software standards, applying their knowledge and expertise to develop robust systems that provide researchers with the tools to access, search, visualise, analyse and meaningfully interpret the data in the CSD.
Knowledge
Using a novel application of existing and new algorithms and methods to explore the highquality structural data and physicochemical properties in the CSD, we can extract new scientific insights to advance structural science worldwide and assist in the making of new discoveries.
Supporting the community
We are committed to the advancement of chemistry and crystallography for the public benefit, serving the global chemistry community by helping to address our users’ challenges through high-quality data, scientific software, and specialist knowledge and expertise.
We offer a selection of products and services free of charge for the benefit of the scientific community. Our services cover a wide range of crystallographic tools, from data deposition, validation, advanced searching, and visualisation to teaching, research, and analysis.
5
Our strategy: advancing structural chemistry worldwide
The main objective of the not-for-profit charity is the general advancement and promotion of the science of chemistry and crystallography in all its branches for the public benefit.
The CCDC’s strategy is to deliver this through continued development of its people, data, science and partnerships, training, education and outreach.
Data
We aim to continue collecting, curating, making available, and learning from structural chemistry data on a deeper, faster, and more interlinked level. Additionally, we will continue to incorporate open and FAIR (Findable, Accessible, Interoperable, Reusable) data requirements.
Over the next five years, CCDC aims to expand its data by incorporating more meta data about solid forms into the CSD. This growth, along with enhanced interlinking of data, is supported by a new, continuously evolving, and scalable database architecture, ensuring a future-proof foundation for an increasingly interconnected structural science universe. Through updated editorial workflows and improved interactions with the wider scientific community and our depositors, we will capture and add more fields and metadata, as well as physicochemical data.
Science and partnerships
We endeavour to be a leader in structural scientific research by working with all our inhouse scientists, our research partners, commercial clients, and our international academic network. We will continue to develop strong partnerships and alliances, furthering our cause, as well as scaling up our global distribution network.
We will continue to invest in new approaches and infrastructure to continue our novel research and regular publishing in the scientific literature, to advance the field.
Training, education and outreach
Through our global training, education, and outreach initiatives, we are committed to advancing structural science and equipping the next generation of scientists. This effort supports the wider adoption of CCDC’s software and data in both academia and industry. A key part of this mission is our growing CSD Champions network: passionate volunteers who use the CSD in research and education. These champions help us engage with new and existing users in their regions, supporting the scientific community through education and outreach. In 2025, CCDC and our CSD Champions delivered over forty training events worldwide.
6
Our strategic aims, vision, and mission
CCDC’s vision was renewed in July 2025 to be the catalyst for solving real world scientific challenges by connecting structural chemistry data, people and scientific tools.
The vision is underpinned by four building blocks:
-
Data: Trusted and curated structural chemistry data that is extended, linked and FAIR, enabling scientific discoveries across disciplines.
-
Community: Guided by our community, we are a collaborative research data hub connecting and supporting academia, industry and the next generation of scientists.
-
Scientific tools: Accessible software and services built on trusted science and data, designed to solve real-world problems across disciplines.
-
Sustainability: A resilient organisation with the people, partnerships, and commercial strength to sustain and grow our scientific impact.
Image to show the four building blocks that underpin CCDC’s renewed vision.
Our values
We have nine core values underpinning everything we do to ensure we achieve our mission. The CCDC and its staff have embedded these values in the ways we work across all levels and functions of the organisation.
-
Community: We serve the global scientific communities for the public benefit.
-
Collaboration: We work together and engage positively with others to achieve our goals.
-
Customer Centricity: We provide a high-quality product and service with an excellent customer experience.
-
Integrity: We act with integrity and communicate honestly and transparently.
-
Innovation: We push boundaries in all that we do and creatively advance understanding.
-
Passion: We are enthusiastic about the services we provide and committed to the people we help.
-
Quality: We are experts in our field, producing trusted resources for our community and customers.
-
Agility: We act in flexible and efficient ways, with a sense of urgency and turn around requests as fast as possible without compromising quality.
-
Diversity: We believe in diversity and inclusion, and we work to create a culture of belonging where everyone is welcome, valued, and respected.
7
Public benefits
The CCDC Board of Trustees holds in high regard the principle of public benefit and requires the executive team, the wider senior leadership, and staff of the CCDC to pursue policies that demonstrate this. At its quarterly meetings, the Board of Trustees reviews ongoing charitable activities to ensure consistency with our charitable objectives. The Board of Trustees is aware of the Charity Commission’s guidance on public benefit and has had regard to it in determining the Charity’s aims and objectives and in the way it carries out its activities.
CCDC staff and trustees in May 2025.
Delivering our vision
In 2025, the Cambridge Structural Database (CSD) grew by 5% to almost 1.4 million structures. This growth resulted from contributions by over 15,000 researchers from 100 countries.
Four data releases were delivered through our desktop software and up to the minute data was provided through our online services, namely Access Structures and WebCSD. Curated data collections, known as CSD Subsets, were also updated alongside our desktop releases to facilitate targeted research. These subsets are often developed in collaboration with external experts and provide a great starting point for specific research projects.
8
Chart showing the growth of the Cambridge Structural Database (CSD).
The CSD Communications initiative, which enables direct sharing of crystal structure data without the need for an associated scientific article, accounted for over 6,000 new entries, representing more than 10% of the year's additions. The total number of structures shared through this method now exceeds 69k. The CCDC also supported researchers worldwide by helping to add entries into the CSD from historical hardcopy, printed information.
Efforts were made to enhance existing data within the CSD:
-
Over 60k entries were enhanced with the addition of information such as bioactivity, natural source and oxidation states.
-
25 new data fields were added to the CSD including data integrity related fields extracted from the deposited data and calculated properties for metal-organic framework (MOF) structures.
-
Over 170k CSD entries were enhanced with improved disorder representations.
-
Over 1M CSD entries were enhanced with associated article titles.
During the year we automated more of our data integrity checks and worked closely with publishers when data integrity issues were identified. By the end of 2025 a total of 1,218 structures had been retracted from the database (up from 1,002) due to data or publication integrity concerns and our users were kept informed through a dedicated FAQ.
In 2025 the CCDC marked the 60th anniversary of the CSD. The celebrations included a series of online panel webinars on frontiers in structural science featuring members of the community; a keynote lecture at the European Crystallographic Meeting (ECM35) titled “Breaking Boundaries, Creating Connections: The Cambridge Structural Database at 60” ; and an evening reception held during ECM35. The reception was jointly organised with FIZ Karlsruhe, the curators of the Inorganic Crystal Structure Database (ICSD), and featured contributions from community representatives including Professor Santiago
9
García-Granda, President of the International Union of Crystallography (IUCr), Professor Marijana Đaković, Past President of the European Crystallographic Association (ECA), and the CCDC’s Chair of Trustees, Professor Susan Bourne. The remaining articles of the Virtual Special Issue of Crystal Growth & Design "Legacy and Future Impact of the Cambridge Structural Database: A Tribute to Dr Olga Kennard" were also published.
The CCDC continued to support our global scientific community, and to further that support, we expanded the CSD Champions network. This volunteer programme helps to train users in more regions. We participated in and supported many international conferences both in-person and virtually, and the CCDC and our CSD Champions delivered over forty workshops at crystallographic schools and training events. These included events in the UK, Poland, Italy, France, Spain, Romania, Canada, USA, Jamaica, Algeria, South Africa, Colombia, Brazil, Argentina and India.
During 2025, the CCDC also ran six free virtual workshops over two series. These online training sessions hosted attendees from all over the world, and overall counted 785 attendees at the live sessions, a similar figure as 2024.
In total, through our in-person and online tutored sessions delivered by CCDC and our CSD Champions, we trained over 1,900 people at live events, with a small growth (1%) compared to 2024.
Map showing the location of people who attended CCDC Virtual Workshops in 2025, countries with at least one attendee shown in blue.
As well as supporting and hosting virtual global events, the CCDC established and enriched its educational resources. These resources include guided step-by-step workshops, how-to videos, and software tips shared on social media to help users explore the CSD and associated software. We also improved and expanded our collection of modules designed
10
for teaching chemistry in high school and undergraduate programmes, covering a range of topics from molecular confirmations to stereochemistry and hapticity.
To inspire the next generation of structural scientists, CCDC hosted an in-person event at the Cambridge Festival with our Crystal Adventures activity. Participants of all ages hunted for the structures of everyday compounds, viewed crystal growth in real time under the microscope, matched proteins to ligands with a card game, and built crystal structure models.
Through the CCDC Engagement Grant programme, we also supported individuals outside CCDC in creating resources or activities to increase school student and public engagement in crystallography and structural science. These included classroom activities, booklets and comics to introduce children to chemistry and crystallography, and an image competition resulting in a calendar. All resources created in 2025 will be shared through the CCDC website once available. Seven new projects were awarded an Engagement Grant at the end of 2025, ranging from educational videos to crystal growing activities. The outputs will be shared in 2026 / early 2027.
As well as supporting scientists to contribute to advancing structural science for the public benefit, the CCDC supported early-stage structural scientists at 20 events worldwide through the provision of early career prizes and sponsorships.
In 2025 CCDC also hosted three students over the European summer months for paid placements. The placements involved typing up legacy data, enrichments to the CSD, connecting morphologies to CSD structures, as well as the creation of educational resources. The 2025 cohort were undergraduate students in the UK. These projects helped the students familiarise themselves with a range of scientific software and learn about the importance of good data management practices before resuming their academic studies.
We also hosted four academics for extended periods; Professor Izabela Madura from the University of Warsaw, Poland; Professor Alice Brink from the University of Free State, South Africa; Dr Aleksandar Višnjevac from Ruđer Bošković Institute, Croatia; Professor Daniele Toti from the Catholic University of the Sacred Heart, Italy. This allowed us to establish new scientific collaborations, discuss joint articles, learn more about how our tools are being used in academia and provided our visitors with the opportunity to learn more about how to use the CSD for their research and teaching.
We continued to promote our Frank H. Allen International Research and Education (FAIRE) programme that provides free access to the CSD and associated software to scientists in eligible countries who may not otherwise have access. In 2025, 10 new institutions were awarded a campus-wide CSD licence under the FAIRE programme, taking the total number of active FAIRE licence holders to 66. Since its launch in 2017, the initiative has supported researchers in publishing over 160 scientific articles in primary research journals.
11
Map showing where our FAIRE programme was used in 2025. Lighter to darker shades represent a growing number of FAIRE holders ranging from one to nine.
Scientific innovation
CCDC has continued to innovate in 2025. Consistent with our mission, we worked across a broad range of chemistry areas: discovery science, pharmaceutical solid-state materials science, particle and surface chemistry, crystal structure prediction, and functional materials domains.
We share our science with our communities in several ways: through integration into our software, publications in the scientific literature, book chapters, webinars, and presenting talks and posters at international conferences.
Examples of key research areas where we have published this year include data-driven generation of conformational ensembles and ternary complexes for PROTAC (Proteolysis Targeting Chimeras) and other chimera systems; a survey of crystallographic quality metrics from crystallographic files (CIFs) in the CSD and combining experiment and prediction to explore surface chemistry and dissolution.
Other key research areas during 2025 were surface property modelling, particle informatics, interaction analysis, aromatics analyser, development of descriptors to support the catalysis community, MOF collection validation, hydrogen bond propensity validation, informatics meets energetics, voids analysis, blind docking, molecular flexibility statistics, AI tools in discovery science, blind docking, ligand preparation, fragment based peptide design, bioisosteric replacement and CSD molecular 3D shape descriptors.
12
Impact of the CCDC in worldwide research
The CCDC’s software and services continue to have impact in research across the world. So far, CCDC reference papers have been cited 2,442 times in publications listed on Web of Science in 2025.
-
1,799 citations cited one of the key database reference papers (i.e. an example of use of the database or use of a piece of our core portfolio, such as Mercury.)
-
404 papers cite the primary CSD reference paper.
-
The number of countries listed that have a publishing author that has cited the CSD at some time since 1960 has grown to 146.
-
The highest contribution in 2025 from a country was from India, followed closely by the USA. Kosovo and Mozambique feature for the first time this year.
Chart showing the worldwide distribution of citation counts (according to Web of Science) for papers citing at least one of the key CCDC reference papers published in 2025. FAIRE-eligible countries are highlighted with a red dot, showing that CCDC’s FAIRE programme to ensure access to data is impactful, allowing scientists in these countries to undertake interesting scientific studies.
While many publications fall into the Web of Science category of ‘Chemistry Multidisciplinary’ or ‘Crystallography’, 67 publication categories were featured in 2025 (119 have featured since the inception of the CCDC). A few unexpected but interesting categories featured this year. For example, one paper discussed co-former use in nutrition. Another paper this year is listed in the category of ‘Forestry’. In this case, the authors used
13
X-Ray crystallography and CCDC software in their analysis of Heartwood formation to understand an aspect of Tree Physiology.
----- Start of picture text -----
4% [4%2%]
5%
28%
8%
9%
14%
12%
14%
Chemistry Multidisciplinary Chemistry Physical
Crystallography Chemistry Inorganic Nuclear
Materials Science Multidisciplinary Biochemistry Molecular Biology
Chemistry Medicinal Chemistry Organic
Pharmacology Pharmacy Computer Science Interdisciplinary Applications
----- End of picture text -----
Chart showing the distribution of topics (according to Web of Science) for papers citing at least one of the key CCDC reference papers published in 2025. The top 10 categories are shown.
CCDC Studentships
CCDC is heavily engaged in the development of the next generation of researchers by supporting research (PhD) studentships through various combinations of direct financial support, software provision, and supervisory support. We are actively supporting five doctoral training centres in the United Kingdom and, in 2025, supported fourteen studentships in total. These include studentships in Italy and Brazil with the remainder based in the UK. All students and their academic supervisors were invited to participate in a dedicated Annual CCDC PhD Student Science Day meeting at the CCDC where they had the opportunity to network and present their research.
A photo of attendees at the CCDC PhD Student Science Day in June 2025.
14
Key product releases
2025 was an impactful year for product releases, with important new features made available to our users. The CCDC delivered 3 significant product launches over 2025, delivering a wide range of functionality in response to user needs. A major highlight was the launch of our new database format.
New database format
One of our most impactful projects of the past few years came to fruition in 2025 as we launched our new database format for the desktop. This project included a capability to store disorder information for more than 165,000 CSD entries, and enables users to work with this disorder natively in our tools, a feature that many users have requested.
A chart showing the rise of disordered structures in the CSD. Yellow shows structures with the improved modelling of how the disorder is represented. Blue shows structures with the historic way (supressed) disorder is represented in the CSD.
Covalent docking
In the Discovery space, we improved the Covalent Docking method in our docking software GOLD to make it faster and easier for our users. The software now automatically detects reactive groups, matches them with compatible residues, and applies the chosen reaction transformation. This advance aids the study of irreversible inhibitors.
15
CSD-Frameworks
The CCDC launched a new product suite in 2025 to better serve functional materials customers. CSD-Frameworks is a porous functional materials design software suite that is used to accelerate metal-organic framework (MOF) and other porous materials research, optimise materials design, and gain deeper insights into porous materials: all using trusted, curated data from the CSD.
PXRD matching and optimisation
The Powder X-ray Diffraction (PXRD) component of our visualisation and analysis software, Mercury, continues to be one of our most used features, and we added big enhancements in 2025, enabling users to import experimental powder patterns and optimise crystal structures against these patterns using the AutoFIDEL algorithm. This provides a powerful yet intuitive tool for PXRD analysis and structure solution.
Force field optimisation and interaction networks
Energetic methods to support the DigiCCAMMS grant program were a major focus in 2025. The grant project aims to extend the CSD-Particle suite to support the digitalisation of pharmaceutical manufacturing. Within this program two new components were launched:
-
The Crystal and Molecule Optimisers provide new functionality and force fields to allow users to natively optimise structures within Mercury and the CSD Python API.
-
Interaction Networks enable our users to find and understand networks of interactions within crystal structures.
Both underpin our work in CSD-Particle to provide capabilities to predict crystal morphology under experimental conditions.
Structure validation
In 2025, in collaboration with FIZ Karlsruhe, we expanded our free CellCheckCSD service to include inorganic structures alongside organic and metal-organic data from the CSD.
CellCheckCSD enables researchers to check, at a very early stage of crystal structure determination, whether a crystal structure is already present in the database, thus avoiding unnecessary and time-consuming redeterminations of known compounds.
In collaboration with the International Union of Crystallography (IUCr) CellCheckCSD was also incorporated into the IUCr journal workflows and their validation service, checkCIF, to aid structural integrity and duplicate checks at the point prior to publication.
16
Looking forward
We will continue to focus on delivering value for our users as we prioritise projects for 2026. A high priority for the centre is delivering and expanding search on the web through our Lattice platform, providing users with an accessible route to probe the CSD without the need for a desktop installation.
The DigiCCAMMS program will continue throughout 2026, delivering enhancements to our CSD-Particle suite with growth face functionality expected to be released in 2026 and a further major launch expected in 2027.
User experience is a vital part of our products and an area which will be a cornerstone of our work in 2026. This will include enhancements to CSD-CrossMiner, a program used to build pharmacophore queries and mine structural data to help in the development of new drug structures. The improvements are expected to make it easier and faster for users to customise pharmacophore queries and to save, reuse, and refine search results as ideas develop. During 2026 we will also be working to improve the user experience across our software suites for Mac users.
2026 will also see significant improvements in how industrial users can manage their proprietary crystal structure data though the delivery of a data management plug-in for our on-site platform. We will also continue to expand and develop the CSD and expect to release more disorder models in the CSD and extend links and connections between CSD entries.
Within the CSD-Materials suite users can anticipate more advanced void analysis tools, designed to increase the understanding of a particular structure and form part of a wider assessment of the risk of a more stable form being identified.
17
Financial review
Principal funding
The CCDC’s principal funds arise from the subscription fee to the CSD and its associated scientific software. Its subscribers are academic research institutions from around the globe and industrial companies, mainly within the pharmaceutical and biotech sectors, with some in other sectors such as agrochemistry, functional materials, big tech, and the chemical industry. The annual contributions required from the worldwide academic community are significantly discounted compared to the contributions requested from industrial subscribers, and special consideration is given to academic users with financial need in historically underrepresented nations. CCDC aims to set income from academic institutions at a level required to maintain the CSD. The income from non-academic users meets the costs of developing the database, enterprise architecture, and related software. Additionally, it enables the CCDC to invest in relevant scientific methods and applications’ research and development.
The CCDC received government grants for specific projects (restricted income) during 2025. It also received donations from its trading subsidiary, the CCDC Services Ltd, under a Deed of Covenant. Since 2023, the CCDC holds an investment portfolio from which it receives dividends that are reinvested.
In 2024, the charity introduced an online donations facility via its website in an effort to generate additional income; however, no funds have been received through this channel to end of 2025. The organisation does not currently have any volunteers to support fundraising activities of this nature and will keep the effectiveness of this facility under review. No complaints were received during the year. The CCDC is not presently registered with the Fundraising Regulator, for which the registration is voluntary.
----- Start of picture text -----
£550,328.00, 5%
£204,723.00, 2%
£753,414.00, 7%
Subscription fees
Trading income
Investment
Restricted income
£8,996,812.00,
86%
----- End of picture text -----
A chart showing the detailed breakdown of 2025 revenue from all sources.
18
----- Start of picture text -----
£10M
£9M
£8M
£7M
£6M
£5M
£4M
£3M
£2M
£1M
£0M
Subscription fees Trading income Investment Restricted income
2024 2025
----- End of picture text -----
A chart showing how the detailed breakdown of 2025 revenue from all sources compares to 2024.
----- Start of picture text -----
£11M
£10,505,277.00
£9,879,753.00
£10M
£9M
£8M
£7M
£6M
£5M
£4M
£3M
2024 2025
----- End of picture text -----
A chart showing total revenue in 2025 compared to 2024.
Revenue grew by 6% in 2025 compared to the previous year. This is largely due to increase in trading income(income generated from trading subsidiary) and restricted income.
19
Subscription fees remain at a similar level as 2024. Total revenue for the year was £10,505,277(2024: £9,879,753).
In 2025, we continued to promote the FAIRE programme that provides free access to the CSD to users who may not otherwise have access; heavy subsidies are also provided to users who have limited funds. The total monetary value of the subsidies amounted to £318,200 (2024: £609,659).
Expenditure
The activities undertaken in the year were carried out within the budget approved by the Board of Trustees. All the expenditures were spent for CCDC’s charitable purpose.
The total charitable expenditure in 2025 was £9,436,518, 13% reduction compared to 2024(£10,800,484).
----- Start of picture text -----
£13M
£376,551
£11M
£164,262
£1,962,420
£9M
£1,539,104
£7M
£5M
£8,461,513
£7,733,152
£3M
£1M
2024 2025
Direct Costs Support Costs Grant Costs
----- End of picture text -----
- A chart to show a breakdown of the expenditure. Direct costs are the costs resulting directly from undertaking the charitable activities, while support costs are the costs incurred to facilitate the activities. All costs have reduced in 2025. Direct Costs reduced by 9% (2025: £7,733,152; 2024: £8,461,513) while support costs decreased by 22% (2025: £1,539,104; 2024: £1,962,420).
Staff costs
Staff costs continue to be the CCDC's largest expenditure. When the CEO stepped down in November 2024, staff recruitment was put on hold while we were recruiting for the new
20
head of the Centre. The new Executive Director was appointed in July 2025. The average total number of staff across the Group decreased from 109 to 96. Total staff costs for 2025 were £7,373,097 (2024: £8,196,052), reflecting a 10% decrease. Despite the lower headcount, CCDC continued to deliver the charitable activities set out in the plan by focusing on the key priorities.
Other operating costs
In response to challenging revenue growth, the Centre has implemented cost control measures to ensure financial stability. Consequently, recruitment costs have decreased compared to last year, from £44,731 in 2024 to £22,577 this year, as we have put recruitment on hold. For the few positions that have been filled, they were mainly recruited directly via our website. Other operational costs, including attending scientific meetings, consultants and legal expenses, have reduced. Cost saving measures are designed to ensure that our resources are managed effectively. Overall, the total operating costs excluding salaries have decreased by 21% compared to 2024, from £2,604,432 to £2,063,421.
In 2025, grants for sponsoring research students totalled £164,262, just below half of the spend in 2024 (£376,551). Lower commitments were made in 2025 as more was committed in previous year where costs were recognised up front. This is to ensure we have sufficient resources to deliver the training programs we are supporting. Three new students started in 2025 as planned. In total, CCDC co-sponsored 16 students this year (2024: 15) across nine UK universities, one Italian university and one Brazilian university.
The CCDC holds an investment portfolio that is managed by Newton Investment Management. It produced an unrealised gain of £900,598 (2024: gain £485,886). This brought the overall financial performance of the CCDC to a surplus of £1,960,505 in 2025 (2024: deficit £444,861).
Investment policy
Since 1987, CCDC has looked to build up its reserves to provide financial stability and to enable it to fund its research and development activities. The primary objective of the investment policy is to preserve the capital and income in the investment portfolio from inflation.
In 2015, the Board of Trustees reviewed the investment policy and as a result, Newton Investment Management Ltd were appointed as our investment managers. The monies were moved from the incumbent Investment Manager and invested into Newton Growth and Income Fund for Charities.
The investment policy sets no specific ethical constraints on the investment portfolio. However, it states that the portfolio should be invested in a socially responsible manner and the investment manager of the portfolio is expected to consider environmental, social, and governance (ESG) issues in their investment analysis and decision-making process, engaging with company management where appropriate.
It is the practice that the investment advisers attend regular meetings with the Board of Trustees and report on the progress of the fund, and the CCDC’s investment into it. Detailed written reports are produced on a quarterly basis that value the portfolio and record its respective performance statistics. An integral part of the regular meetings is a detailed discussion on the content of the report with particular reference to the performance aspect. The table below shows the fund’s performance in the last five years.
21
*The 50% FTSE All Share, 25% FTSE World ex UK, 20% FTSE Gov All Stocks, 5% 7 Day compounded SONIA (cash) is used as a comparator for this portfolio. The Fund does not aim to replicate either the composition or the performance of the performance benchmark.
The Executive Team at the CCDC review monthly reports from the investment managers. The Trustees review the performance of the investment portfolio on a half-yearly basis. A more formal independent review of the investment manager and investment policy is carried out at least every five years or more frequently if circumstances require. An independent review was carried out during 2020. The Board were satisfied with the performance of Newton Growth & Income Fund for Charities. It was decided by the Board at that time to continue investing with Newton.
The fund produced a positive return in 2025 but underperformed its performance benchmark.
The Board made the decision to reinvest dividends in November 2022. The switch of fund from Income class to Accumulation class was implemented in January 2023. During 2025 £173,975 were reinvested (2024: £158,531). The value of the portfolio was £8,598,864 at the end of the year, representing an overall gain of £1,074,573 (2024: gain £644,417).
A photo taken from inside the CCDC building in Cambridge.
22
Reserves
The CCDC’s Reserves Policy is to maintain sufficient levels of reserves to enable normal operating activities to continue over a period of six months (at least) should a shortfall in income occur; it should take account of potential risks and contingencies that may arise from time to time. The Reserves Policy requires the retention of income sufficient to encompass:
-
The balance on tangible and intangible fixed assets for use by the Charity to avoid having to liquidate functional assets to release cash less all loans associated directly with these assets.
-
To cover 50% of the direct costs and support costs, agreed in the budget or at the Board of Trustees’ meetings.
-
Funds to enable designated expenses and provisions that are anticipated to be greater than £200,000 (less any external funding of them).
The reserves policy is reviewed annually to take into consideration perceived risks and opportunities.
At the end of 2025, CCDC’s free reserve was £8,391k (2024: £6,282k). This is equivalent to approximately 88% of 2026 budgeted costs.
Our present position is:
Unrestricted Reserves
Designated Funds
31 Dec 2025 £10,774k
£2,382k
Fixed Asset Fund £2,109k Research and Development Fund £173k Sponsorship and Outreach Fund £0k Pension Provision Fund £0k Sustainability Fund £100k
Free Reserves
£8,391k
23
Structure, management, and governance
CCDC was incorporated as a Company Limited by Guarantee on 18 August 1987. It has no share capital and is a registered charity. The guarantee of each member is £1. The governing documents are the Articles of Association of the company (as amended November 2025).
In addition to CCDC, the charity operates the following subsidiaries:
-
CCDC Services Ltd (formerly CCDC Software Ltd.) – is a wholly owned trading subsidiary of the CCDC. It was established in 1998 to deliver bespoke software development as necessary to meet the requirements of CCDC’s charitable status. Since 2015, its trading activities have evolved towards professional services from software development. 2019 was the first year when all its revenues arose from professional services. The CCDC’s Board of Trustees and the Director of CCDC Software Ltd approved of the name change to best reflect the trading activities of the company in May 2019. The name change was officially registered with Companies House on 28th July 2019. The company is located at the same address as CCDC. The Directors of CCDC Services Limited consist of two trustees of the CCDC, and the Executive Director of the CCDC. The Directors meet at least once a year . The Directors of the CCDC Services Limited do not receive remuneration for their service. An executive summary report of the key activities and performance of the entity is provided at the Board of Trustees’ meeting.
-
CCDC Inc . – is a wholly-owned service subsidiary of the CCDC incorporated in the state of New Jersey in September 2013, with legal address of One Boston Place, Suite 2600, Boston, MA 02108, USA. The fully virtual team spans the USA coast to coast, and works collaboratively with global colleagues, users, and the wider scientific community to advance the overall group mission across the Americas. They support Education & Outreach, Customer Support, Customer Success, Research Partnerships, Business Development, and Marketing in the region on behalf of the parent company.
Governance
The Charity is governed by the Board of Trustees who delegate operational management to the Executive Director (ED), supported by an Executive Leadership Team (ELT) covering all functions of the organisation, underpinned by decision making boards focussing on specific areas of the Centre.
In accordance with governing documents, potential Trustees are appointed by the Board based on recommendations by the Nominations Committee and on their specific skills, location, and diversity. Potential Trustees are sent an induction pack covering their obligations under Charity and Company Law, Articles of Association, Memorandum of Association and Codes of Practice, company policies, and a non-disclosure agreement. Potential Trustees are invited to attend Board meetings as observers. After that, the Board of Trustees and the individual consider their suitability to act as a Trustee ahead of their formal acceptance to the post at the Annual General Meeting (AGM). Upon acceptance and appointment, Trustees receive an induction to the business, which covers key aspects of the organisation, its operations, and salient Health and Safety information.
The Board of Trustees usually meets at the CCDC Cambridge UK office twice a year in May and November, with two further virtual meetings in February and August. Working to a
24
standing agenda, the meetings with the ED and the ELT provide oversight on the performance and progress of the Charity in line with strategy. Progress reports from all functions are presented to the Board at these meetings from the corresponding executive team members. In addition, the Board also receives management account reports regularly from the ED and produced by CCDC’s finance team, which include the financial performance, the investment performance and cash balances. The opportunity for all staff to interact with Trustees is encouraged and was specifically scheduled as part of the onsite meetings. All staff members have the option to ask questions in quarterly Q&A sessions at All-Staff meetings, where some trustees are usually present as well.
In addition to Board meetings, the Board members engage regularly with the ED to address any matters arising from the meetings in a timely manner, to address any issues that need action, or to discuss trends and any matters of interest to the advancement of the charity. In special cases, extra joint calls were convened as needed.
During 2025, meetings of the Board Committees, Nomination, Audit, Risk, and Remuneration were held in accordance with their terms of reference.
Nomination Committee
The purpose of the Nominations Committee is primarily to ensure that:
-
The Board and its committees should have the appropriate balance of skills, experience, independence, and knowledge of CCDC to enable them to discharge their respective duties and responsibilities effectively.
-
There should be a formal, rigorous, and transparent procedure for the appointment of new trustees to the Board of CCDC.
-
There should be an efficient, fair, and thorough process on which the Nominations Committee leads for recommendations of appointments to the Board.
Audit Committee
The purpose of the Audit Committee is to ensure that:
- The Charity’s annual accounts, budgets, forecasts, and plans are reflected accurately by management accounts and other financial reports presented to them by the finance team.
Remuneration Committee
The purpose of the Remuneration Committee is to ensure that:
Assurance is provided to the Board that the CCDC has an effective and competitive People and Pay Strategy in place that supports the delivery of the strategy, promoting an effective, productive, high-performing, and diverse workforce.
All issues are overseen relating to the remuneration of staff, with specific responsibility for making recommendations to the Board regarding the Remuneration Policy and the executive’s remuneration.
25
Risk Committee
The purpose of the Risk Committee is primarily to ensure that:
-
Risks to the organisation (including its subsidiaries), assets, and reputation of CCDC are identified, assessed, and monitored.
-
A risk management framework is created and implemented.
-
A register of risks is maintained.
-
A disaster response strategy and business continuity plan are in place.
Management and staffing
The day-to-day management of the CCDC is delegated by the Board of Trustees to the Executive Director (ED). Operational management is delivered by the Executive Leadership Team (ELT) and other managers who, in 2025, were:
Suzanna Ward Executive Director (appointed July 2025) Head of Data and Community (until June 2025) Garry O’Connor Head of Science Jonathan Betts Head of Commercial (departed August 2025) James Ellis Head of Operations (departed July 2025) Bing-Bing Waterman Head of Finance Michelle Christie Head of Human Resources and Organisational Design Matthew Lightfoot Interim Head of Data and Community (from July 2025) Tracy Allgood Joint Interim Head of Commercial (from September 2025) Marie Clements Joint Interim Head of Commercial (from September 2025)
These individuals constitute the Charity’s key management personnel. They provide reports for the Board of Trustees in support of effective governance and attend Board of Trustees meetings to present operational reports, position papers, and strategic progress.
On 1 July 2025, the Trustees appointed Suzanna Ward as Executive Director (ED) of the CCDC, a role previously titled Chief Executive Officer (CEO). Following the departure of the former CEO in November 2024, and prior to the appointment of the new ED, the responsibilities of this role were carried out collectively by the ELT, under the guidance of the Trustees.
During 2025 the CCDC commenced recruitment for a Head of Commercial and a Head of Technology and Product following the departures of the Head of Commercial and Head of Operations. Interim arrangements were put in place to ensure continuity of leadership.
26
Remuneration policy
The Board of Trustees give their time freely and no trustee received remuneration during the year. Details of trustees’ expenses are disclosed in Note 12 to the accounts. The Board delegates the directing, controlling, and day-to-day operation of the Charity to the ED, who is supported by key management personnel.
The pay of senior staff is reviewed annually and adjusted in line with the CCDC’s pay policy, which applies to all employees and is approved by the Board of Trustees as part of the annual budget process. The Remuneration Committee oversees any recommended salary changes or amendments to the organisation’s pay policy and considers relevant market trends supported by up-to-date benchmarking data provided by management.
Risk management
The leadership team maintains a register of key risks to the organisation, which covers the following areas:
-
Business: Staffing, External Dependencies, External Threats, Reputation, Scientific Fraud
-
Finance: Revenue, Expenditure, Financial Fraud
-
Compliance: Health and Safety, Governance, GDPR
-
Data and IT: Protection of Data Assets, IT Infrastructure and cybersecurity
-
Building: Core Infrastructure, Fire, Lease.
Risk Register entries detail the likelihood and impact of risks occurring, the steps the organisation takes to mitigate these and areas where further action is required.
The Trustees have oversight of risks facing the organisation through the Risk Committee, which reviews the Risk Register at least once a year. Membership of the committee is kept under review. Day-to-day management of the risk register resides with the Executive Director.
Key threat types and approaches taken for mitigating these are summarised in the table below:
| below: | |
|---|---|
| Threat Type | Approach |
| Data Assets Our core mission in structural science is underpinned by the CSD, a high-quality database respected across our community. |
Our data assets drive significant value for the CCDC and we continually invest in technology and quality management to ensure data is available, secure and trusted as a reliable and up to date source of knowledge for our users. Our core data product has been certified as trustworthy by a third party (CoreTrustSeal) to validate our approach. |
| Business Performance The work of CCDC is almost entirely self-funded through licensingof softwareproducts, |
Revenues and costs are budgeted annually with monthly assessments made against the forecast at a departmental level. In 2026 we plan to achieve |
27
| database subscriptions and associated services. In addition to product development, our work also covers scientific research, sponsorship of PhD studentships and training. Productivity improvements help us maximise the charitable impact of our income. |
high levels of customer retention and explore new applications for our data. We maintain bank accounts in multiple currencies to avoid spot-price currency conversion rates into pound sterling. We keep our use of technologies and suppliers under review in order to support productivity improvements. Our product and service investments are kept under review, with a new team structure being implemented to drive customer centricity and more effective product delivery. |
|---|---|
| Technology Generative AI approaches need high quality data assets such as the CSD to train on. Technology improvements can be used to abuse the open access versions of our offer. |
We respond to unlicenced use of the CSD in derived models and systems and we keep the licencing terms for such use under review. We monitor the use of our free services and keep control measures under review to balance easy access to products and services with the need to generate the revenue needed to ensure our organisation remains financially viable. We have used the UK Government’s highly respected CyberEssentials standard and other third party analyses to maintain appropriate levels of cyber-security. |
Going concern
The CCDC ended 2025 in a strong financial position. The organisation delivered a surplus of £1.96m, a significant improvement compared with both the budgeted deficit of £168k and the prior year’s deficit of £445k. Total revenue for the year was £10.5m, representing growth on the previous year and exceeding budget expectations.
The Centre continues to maintain strong assets and cash reserves, supported by solid investment fund performance during the year. Together, these factors provide assurance that the organisation has sufficient resources to meet its obligations and maintain operations for at least the next 12 months.
The Board has reviewed the Centre’s financial forecasts, cash flow projections and risk assessments. Having considered these, the Board has a reasonable expectation that the CCDC has adequate resources to continue in operational existence for the foreseeable future.
28
Looking into the future
The organisational changes made during 2025, together with the appointment of a new Executive Director, provide a clearer structure for the next phase of the CCDC’s work. The updated vision introduced during the year will guide priorities across data, software and community activity.
The external environment is expected to remain challenging, shaped by global economic conditions, changes in research funding and wider market pressures. These factors will continue to be monitored as part of the Centre’s planning and risk management processes.
In the coming period, the Centre expects to continue investing in the development and long-term sustainability of its core datasets and scientific tools, ensuring they remain aligned with the needs of researchers and educators. This includes work to support the effective use of the CSD in computational approaches such as artificial intelligence, while maintaining the integrity and sustainability of the underlying data. The Centre also plans to expand cloud and web-based functionality to improve accessibility and support users working across different environments and institutions.
- As part of its focus on long term sustainability and operational efficiency, during 2026 the - Centre plans to transition the employment of its US based staff to an Employer of Record model, consistent with arrangements already used elsewhere outside the UK. CCDC Inc. will remain in place, but this administrative change is expected to reduce overhead and complexity and will not impact staff, users, partners or customers in the United States.
Ongoing engagement with the structural science community will remain central to planning. This includes continued collaboration with key partners such as the CCDC’s Crystal Form Consortium, Research Partners and the CSD Champions, whose insights collectively help inform the development of the organisation’s resources and services.
Overall, the CCDC’s renewed vision, to act as a catalyst for solving real world scientific challenges by connecting structural chemistry data, people and scientific tools, will remain central to its direction. Guided by four focus areas of Data, Community, Scientific Tools and Sustainability, the organisation is well positioned to continue supporting the evolving needs of structural science community.
The image shows the CCDC CSD timeline in the Cambridge office.
29
Reference and administrative details of the Charity, its trustees and advisers
FOR THE YEAR ENDED 31 DECEMBER 2025
Trustees
Professor Alessia Bacchi Professor Jonathan M Goodman Dr Nigel Pitchford, Vice Chair Professor Susan Bourne, Chair Dr Ola Engkvist Dr Ye Li Professor Emerita Jennifer Martin Anita De Waard
Company Secretary
HS Secretarial Limited 50/60 Station Road Cambridge CB1 2JH Company registered number 02155347 Charity registered number 800579 Registered office 12 Union Road Cambridge CB2 1EZ
Executive Director
Suzanna Ward (Appointed 1 July 2025)
Independent Auditors
MHA Building 4 Foundation Park Roxborough Way Maidenhead SL6 3 UD
30
Bankers
Barclays Bank Plc Cambridge CB2 3AA
Lloyds Bank PO Box 1000 Andover BX1 1LT
Solicitors
HCR Hewitsons 50-60 Station Road Cambridge CB1 2JH
Investment Advisers
Newton Investment Management Limited 160 Queen Victoria Street London EC4V 4LA
31
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
(A Company Limited by Guarantee)
STATEMENT OF TRUSTEES' RESPONSIBILITIES FOR THE YEAR ENDED 31 DECEMBER 2025
The Trustees (who are also the directors of the Charity for the purposes of company law) are responsible for preparing the Trustees' Report including the Strategic Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
Company law requires the Trustees to prepare financial statements for each financial year. Under company law, the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Group and the Charity and of their incoming resources and application of resources, including their income and expenditure, for that period. In preparing these financial statements, the Trustees are required to:
-
select suitable accounting policies and then apply them consistently;
-
observe the methods and principles of the Charities SORP (FRS 102);
-
make judgements and accounting estimates that are reasonable and prudent;
-
state whether applicable UK Accounting Standards (FRS 102) have been followed, subject to any material departures disclosed and explained in the financial statements;
-
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Group will continue in business.
The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the Group and the Charity's transactions and disclose with reasonable accuracy at any time the financial position of the Group and the Charity and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Group and the Charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Approved by order of the members of the Board of Trustees and signed on its behalf by:
................................................
Prof S Bourne
Chair of the Board of Trustees Date: 28 May 2026
Page 32
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
(A Company Limited by Guarantee)
INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
Opinion
We have audited the financial statements of The Cambridge Crystallographic Data Centre (the 'parent charitable company') and its subsidiaries (the 'group') for the year ended 31 December 2025 which comprise the Consolidated Statement of Financial Activities, the Consolidated Balance Sheet, the Charity Balance Sheet, the Consolidated Statement of Cash Flows and the related notes, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).
In our opinion the financial statements:
-
give a true and fair view of the state of the Group's and of the parent charitable company's affairs as at 31 December 2025 and of the Group's incoming resources and application of resources, including its income and expenditure for the year then ended;
-
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-
have been prepared in accordance with the requirements of the Companies Act 2006.
Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the Group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the United Kingdom, including the Financial Reporting Council's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the Trustees' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Group's or the parent charitable company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the Trustees with respect to going concern are described in the relevant sections of this report.
Page 33
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
(A Company Limited by Guarantee)
INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE (CONTINUED)
Other information
The other information comprises the information included in the Annual Report other than the financial statements and our Auditor's Report thereon. The Trustees are responsible for the other information contained within the Annual Report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
Opinion on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
-
the information given in the Trustees' Report including the Strategic Report for the financial year for which the financial statements are prepared is consistent with the financial statements.
-
the Trustees' Report and the Strategic Report have been prepared in accordance with applicable legal requirements.
Matters on which we are required to report by exception
In the light of our knowledge and understanding of the charitable company and its environment obtained in the course of the audit, we have not identified material misstatements in the Trustees' Report including the Strategic Report.
We have nothing to report in respect of the following matters in relation to which Companies Act 2006 requires us to report to you if, in our opinion:
-
the parent charitable company has not kept adequate and sufficient accounting records, or returns adequate for our audit have not been received from branches not visited by us; or
-
the parent charitable company financial statements are not in agreement with the accounting records and returns; or
-
certain disclosures of Trustees' remuneration specified by law are not made; or
-
we have not received all the information and explanations we require for our audit.
Page 34
(A Company Limited by Guarantee)
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE (CONTINUED)
Responsibilities of trustees
As explained more fully in the Trustees' Responsibilities Statement, the Trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the Trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, the Trustees are responsible for assessing the Group's and the parent charitable company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Trustees either intend to liquidate the Group or the parent charitable company or to cease operations, or have no realistic alternative but to do so.
Auditor's responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditor's Report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:
-
Enquiry of management around actual and potential litigation and claims;
-
Performing audit work over the risk of management override of controls, including testing of journal entries and other adjustments for appropriateness, evaluating the business rationale of significant transactions outside the normal course of business and reviewing accounting estimates for bias;
-
Reviewing minutes of meetings of those charged with governance;
-
Reviewing financial statement disclosures and testing to supporting documentation to assess compliance with laws and regulations.
Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.
A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our Auditor's Report.
Page 35
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
(A Company Limited by Guarantee)
INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE (CONTINUED)
Use of our report
This report is made solely to the charitable company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the charitable company's members those matters we are required to state to them in an Auditor's Report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and its members, as a body, for our audit work, for this report, or for the opinions we have formed.
Carina Ralfs MSci (Hons) PhD FCA (Senior Statutory Auditor)
for and on behalf of
MHA Maidenhead, United Kingdom
Date: 01 June 2026
MHA is the trading name of MHA Audit Services LLP, a limited liability partnership in England and Wales (registered number OC455542).
Page 36
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
(A Company Limited by Guarantee)
CONSOLIDATED STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING INCOME AND EXPENDITURE ACCOUNT) FOR THE YEAR ENDED 31 DECEMBER 2025
| Note Income from: Donations and legacies 4 Charitable activities 5 Other trading activities 7 Investments 8 Total income Expenditure on: Charitable activities 10 Total expenditure Net income/(expenditure) before net gains on investments Net gains on investments 15 Net income/(expenditure) before taxation Taxation 13 Net income/(expenditure) after taxation carried forward |
Unrestricted funds 2025 £ 200 8,996,612 753,414 204,723 9,954,949 8,458,405 8,458,405 1,496,544 900,598 2,397,142 (8,852) 2,388,290 |
Restricted funds 2025 £ - 550,328 - - 550,328 978,113 978,113 (427,785) - (427,785) - (427,785) |
Total funds 2025 £ 200 9,546,940 753,414 204,723 10,505,277 9,436,518 9,436,518 1,068,759 900,598 1,969,357 (8,852) 1,960,505 |
Total funds 2024 £ 55 9,087,546 613,434 178,718 9,879,753 10,800,484 10,800,484 (920,731) 485,886 (434,845) (9,962) (444,807) |
|---|---|---|---|---|
Page 37
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
(A Company Limited by Guarantee)
CONSOLIDATED STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING INCOME AND EXPENDITURE ACCOUNT) (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025
| Note Net income/(expenditure) after taxation brought forward Transfers between funds 20 Net movement in funds before other recognised gains/(losses) Other recognised gains/(losses): Other losses Net movement in funds Reconciliation of funds: Total funds brought forward Net movement in funds Total funds carried forward |
Unrestricted funds 2025 £ 2,388,290 (435,839) 1,952,451 - 1,952,451 8,821,130 1,952,451 10,773,581 |
Restricted funds 2025 £ (427,785) 435,839 8,054 - 8,054 (8,054) 8,054 - |
Total funds 2025 £ 1,960,505 - 1,960,505 - 1,960,505 8,813,076 1,960,505 10,773,581 |
Total funds 2024 £ (444,807) - (444,807) (54) (444,861) 9,257,937 (444,861) 8,813,076 |
|---|---|---|---|---|
The Consolidated Statement of Financial Activities includes all gains and losses recognised in the year.
The notes on pages 43 to 75 form part of these financial statements.
Page 38
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
(A Company Limited by Guarantee) REGISTERED NUMBER: 02155347
CONSOLIDATED BALANCE SHEET AS AT 31 DECEMBER 2025
| Note Fixed assets Tangible assets 14 Investments 15 Current assets Debtors 16 Cash at bank and in hand Current liabilities Creditors: amounts falling due within one year 17 Net current assets / liabilites Total assets less current liabilities Creditors: amounts falling due after more than one year 18 Total net assets Charity funds Restricted funds 20 Unrestricted funds 20 Total funds |
3,454,426 2,911,072 6,365,498 (5,563,683) |
2025 £ 2,108,870 8,598,864 10,707,734 801,815 11,509,549 (735,968) 10,773,581 - 10,773,581 10,773,581 |
3,752,830 1,637,244 5,390,074 (5,626,143) |
2024 £ 2,200,117 7,524,291 9,724,408 (236,069) 9,488,339 (675,263) 8,813,076 (8,054) 8,821,130 8,813,076 |
|---|---|---|---|---|
The Trustees acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and preparation of financial statements.
The financial statements were approved and authorised for issue by the Trustees and signed on their behalf by:
................................................
Prof S Bourne
Chair of the Board of Trustees Date: 28 May 2026
The notes on pages 43 to 75 form part of these financial statements.
Page 39
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE (A Company Limited by Guarantee) REGISTERED NUMBER: 02155347
CHARITY BALANCE SHEET AS AT 31 DECEMBER 2025
| Note Fixed assets Tangible assets 14 Investments 15 Current assets Debtors 16 Cash at bank and in hand Current liabilities Creditors: amounts falling due within one year 17 Net current assets / liabilites Total assets less current liabilities Creditors: amounts falling due after more than one year 18 Total net assets Charity funds Restricted funds 20 Unrestricted funds 20 Total funds |
3,948,485 2,248,759 6,197,244 (5,762,581) |
2025 £ 2,108,870 8,762,353 10,871,223 434,663 11,305,886 (735,968) 10,569,918 - 10,569,918 10,569,918 |
3,951,250 977,276 4,928,526 (5,552,386) |
As restated 2024 £ 2,200,117 7,687,780 9,887,897 (623,860) 9,264,037 (675,263) 8,588,774 (8,054) 8,596,828 8,588,774 |
|---|---|---|---|---|
Page 40
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
(A Company Limited by Guarantee) REGISTERED NUMBER: 02155347
CHARITY BALANCE SHEET (CONTINUED) AS AT 31 DECEMBER 2025
The Charity's net movement in funds for the year was £1,981,144 (2024 - £(468,440)).
The Trustees acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and preparation of financial statements.
The financial statements were approved and authorised for issue by the Trustees and signed on their behalf by:
................................................
Prof S Bourne
Chair of the Board of Trustees Date: 28 May 2026
The notes on pages 43 to 75 form part of these financial statements.
Page 41
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
(A Company Limited by Guarantee)
CONSOLIDATED STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31 DECEMBER 2025
| Note Cash flows from operating activities Net cash used in operating activities 22 Cash flows from investing activities Dividends, interests and rents from investments Purchase of tangible fixed assets Purchase of investments Net cash provided by/(used in) investing activities Change in cash and cash equivalents in the year Cash and cash equivalents at the beginning of the year Cash and cash equivalents at the end of the year 23 |
2025 £ 1,266,261 204,723 (23,181) (173,975) 7,567 1,273,828 1,637,244 2,911,072 |
2024 £ (989,662) 178,718 (21,299) (161,624) (4,205) (993,867) 2,631,111 1,637,244 |
|---|---|---|
The notes on pages 43 to 75 form part of these financial statements
Page 42
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE (A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
1. General information
The company is a company limited by guarantee. The members of the company are the Trustees named on page 30. In the event of the company being wound up, the liability in respect of the guarantee is limited to £1 per member of the company.
2. Accounting policies
2.1 Basis of preparation of financial statements
The financial statements have been prepared in accordance with the Charities SORP (FRS 102) - Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.
The Cambridge Crystallographic Data Centre meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy.
The Consolidated Statement of Financial Activities (SOFA) and Consolidated Balance Sheet consolidate the financial statements of the Charity and its subsidiary undertaking. The results of the subsidiary are consolidated on a line by line basis.
The Charity has taken advantage of the exemption allowed under section 408 of the Companies Act 2006 and has not presented its own Statement of Financial Activities in these financial statements.
2.2 Going concern
The Cambridge Crystallographic Data Centre meets its day to day working capital requirements through the cash it holds and generates. The Charity undertakes a regular process of reviewing forecasts and projections to ensure that it has adequate resources for its continued operations and can draw on its investment portfolio to support its planned activities if required.
Management continuously reviews the trends in the biopharmaceutical market and wider growth trends in the technology and science fields. CCDC's data and scientific software offerings remain in good demand, and can furthermore help address new trends such as artificial intelligence, and the investments that are going into those efforts.
The consolidated balance sheet shows a net current asset position of £801,815 at the year end (2024: net current liability of £236,069). This is due to higher cash balance at the year end of £2,911,072. Creditors falling due within one year of £5,563,683 are mostly subscriptions in advance of £4,947,725.
The Trustees have a reasonable expectation that the Charity has adequate resources to continue operational existence for at least 12 months from date of approval of the accounts. For this reason, the Charity continues to adopt the going concern basis in preparing its financial statements
Page 43
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
(A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
2. Accounting policies (continued)
2.3 Income
All income is recognised once the Charity has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably.
Subscription income is recognised over the period to which it relates, with income being received in advance deferred.
Trading income, consisting of software and consultancy advice is recognised as supplied while maintenance and support services are recognised over the period to which they relate.
Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the company; this is normally upon notification of the interest paid or payable by the bank. Dividends are recognised once the dividend had been declared and notification has been received of the dividend due.
Grants are included in the Consolidated Statement of Financial Activities on a receivable basis. The balance of income received for specific purposes but not expended during the period is shown in the relevant funds on the Balance Sheet. Where income is received in advance of entitlement of receipt, its recognition is deferred and included in creditors as deferred income. Where entitlement occurs before income is received, the income is accrued.
2.4 Expenditure
Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably.
Support costs are those costs incurred directly in support of expenditure on the objects of the company and include project management carried out at Headquarters. Governance costs are those incurred in connection with administration of the Charity and compliance with constitutional and statutory requirements.
Charitable activities and governance costs are costs incurred on the Charity's operations, including support costs and costs relating to the governance of the company apportioned to charitable activities based on staff roles and time.
Grants payable are charged in the year when the offer is made except in those cases where the offer is conditional, such grants being recognised as expenditure when the conditions attaching are fulfilled. Grants offered subject to conditions which have not been met at the year end are noted as a commitment, but not accrued as expenditure.
2.5 Termination payments
Termination payments are expensed when the Charity can no longer withdraw the offer of these payments.
Page 44
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
(A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
2. Accounting policies (continued)
2.6 Foreign currencies
Monetary assets and liabilities denominated in foreign currencies are translated into sterling at rates of exchange ruling at the reporting date using HMRC monthly rate.
Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction.
Exchange gains and losses are recognised in the Consolidated Statement of Financial Activities.
2.7 Taxation
The Charity is considered to pass the tests set out in Paragraph 1 Schedule 6 of the Finance Act 2010 and therefore it meets the definition of a charitable company for UK corporation tax purposes. Accordingly, the Charity is potentially exempt from taxation in respect of income or capital gains received within categories covered by Chapter 3 Part 11 of the Corporation Tax Act 2010 or Section 256 of the Taxation of Chargeable Gains Act 1992, to the extent that such income or gains are applied exclusively to charitable purposes.
2.8 Tangible fixed assets and depreciation
Tangible fixed assets costing £10,000 or more are capitalised and recognised when future economic benefits are probable and the cost or value of the asset can be measured reliably.
A review for impairment of a fixed asset is carried out if events or changes in circumstances indicate that the carrying value of any fixed asset may not be recoverable. Shortfalls between the carrying value of fixed assets and their recoverable amounts are recognised as impairments. Impairment losses are recognised in the Statement of Financial Activities.
The cost of replacing and upgrading scientific computer equipment is written off as maintenance to scientific equipment in the income and expenditure account.
Assets in the course of construction are included at costs incurred to date. Depreciation on these assets is not charged until they are brought into use.
Tangible fixed assets are carried at cost, net of depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost of fixed assets, less their estimated residual value, over their expected useful live
Depreciation is provided on the following bases:
- Long-term leasehold property 2% straight-line - Fixtures, fittings and equipment 25% reducing balance and 5 years straight line
Page 45
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
(A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
2. Accounting policies (continued)
2.9 Investments
Fixed asset investments are a form of financial instrument and are initially recognised at their transaction cost and subsequently measured at fair value at the Balance Sheet date, unless the value cannot be measured reliably in which case it is measured at cost less impairment. Investment gains and losses, whether realised or unrealised, are combined and presented as ‘Gains/(Losses) on investments’ in the Consolidated Statement of Financial Activities.
Investments in subsidiaries are valued at cost less provision for impairment.
2.10 Debtors
Trade and other debtors are recognised at the settlement amount after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.
2.11 Cash at bank and in hand
Cash at bank and in hand includes cash and short-term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.
2.12 Liabilities and provisions
Liabilities are recognised when there is an obligation at the Balance Sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably.
Liabilities are recognised at the amount that the Charity anticipates it will pay to settle the debt or the amount it has received as advanced payments for the goods or services it must provide.
Provisions are measured at the best estimate of the amounts required to settle the obligation. Where the effect of the time value of money is material, the provision is based on the present value of those amounts, discounted at the pre-tax discount rate that reflects the risks specific to the liability. The unwinding of the discount is recognised in the Consolidated Statement of Financial Activities as a finance cost.
2.13 Financial instruments
The Group only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method.
Page 46
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
(A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
2. Accounting policies (continued)
2.14 Pensions
The Charity participates in the Universities Superannuation Scheme, a defined benefit and defined contribution hybrid scheme which is externally funded and contracted out of the State Earningsrelated Pension Scheme. The fund is valued every three years by a professionally qualified independent actuary using the projected unit method, the rates of contribution payable being determined by the trustees on the advice of the actuary. In the intervening years, the actuary reviews the progress of the scheme. Pension costs are accounted for over the period during which the Charity benefits from the employees services.
The Charity also participates in the Cambridge University Assistants' Contributory Pension Scheme (CUACPS) which is a defined benefit and defined contribution hybrid scheme. The Charity's contributions are affected by a surplus or deficiency in the CUACPS.
For both schemes, the Charity is unable to identify its share of the underlying assets and liabilities in the Scheme on a consistent and reasonable basis. The Charity therefore accounts for its contributions to the schemes as if it were a defined contribution scheme.
The Charity operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Charity pays fixed contributions into a separate entity. Once the contributions have been paid the Charity has no further payment obligations.
The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Charity in independently administered funds.
2.15 Fund accounting
General funds are unrestricted funds which are available for use at the discretion of the Trustees in furtherance of the general objectives of the Group and which have not been designated for other purposes.
Designated funds comprise unrestricted funds that have been set aside by the Trustees for particular purposes. The aim and use of each designated fund is set out in the notes to the financial statements.
Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors or which have been raised by the Group for particular purposes. The costs of raising and administering such funds are charged against the specific fund. The aim and use of each restricted fund is set out in the notes to the financial statements.
Investment income, gains and losses are allocated to the appropriate fund.
Page 47
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
(A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
3. Critical accounting estimates and areas of judgement
Estimates and judgements are continually evaluated and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Critical accounting estimates and assumptions:
The Charity makes estimates and assumptions concerning the future. The resulting accounting estimates and assumptions will, by definition, seldom equal the related actual results. The estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year are discussed below.
Critical areas of judgment:
FRS 102 makes the distinction between a group pension plan and a multi-employer pension scheme. A group plan consists of a collection of entities under common control typically with a sponsoring employer. A multi-employer scheme is a scheme for entities not under common control and represents (typically) an industry-wide scheme such as that provided by USS. The accounting for a multi-employer scheme where the employer has entered into an agreement with the scheme that determines how the employer will fund a deficit results in the recognition of a liability for the contributions payable that arise from the agreement (to the extent that they relate to the deficit) and the resulting expense is recognised in the Consolidated Statement of Financial Activities. The Executive Committee are satisfied that the scheme provided by USS meets the definition of a multi-employer scheme and has therefore recognised the discounted fair value of the contractual contributions under the funding plan in existence at the date of approving the financial statements.
4. Income from donations and legacies
| Unrestricted funds 2025 £ Donations 200 Total 2024 55 |
Total funds 2025 £ 200 55 |
Total funds 2024 £ 55 |
|---|---|---|
Page 48
(A Company Limited by Guarantee)
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
5. Income from charitable activities
| Unrestricted funds 2025 £ Scientific Activity - Subscription Fees 8,723,604 Grant income 113,734 Royalty income 159,274 8,996,612 Total 2024 8,966,989 |
Restricted funds 2025 £ - 550,328 - 550,328 120,557 |
Total funds 2025 £ 8,723,604 664,062 159,274 9,546,940 9,087,546 |
Total funds 2024 £ 8,656,734 266,636 164,176 9,087,546 |
|---|---|---|---|
During the year, the unrestricted funds totalled £8,996,612 (2024: £8,966,989) which was made up of £8,723,604 (2024: £8,656,734) of subscription fees, £113,734 (2024: £146,079) of grant income and royalty income of £159,274 (2024: £164,176). The restricted funds totalled £550,328 (2024: £120,557) which was made up of grant income.
6. Turnover
The whole of the turnover is attributable to the principal activities of the Charity.
A geographical split of turnover is disclosed as follows: United Kingdom 23% (2024 - 23%) , Other EU 24% (2024 - 25%) and Rest of the World 53% (2024 - 52%).
Page 49
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
(A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
7. Income from other trading activities
Income from non charitable trading activities
| Unrestricted funds 2025 £ Sales 753,414 Total 2024 613,434 |
Total funds 2025 £ 753,414 613,434 |
Total funds 2024 £ 613,434 |
|---|---|---|
The wholly owned trading subsidiary CCDC Services Limited is incorporated in the United Kingdom and pays all of its profits to the charity under a deed of covenant. The summary financial performance of the subsidiary is shown in note 15.
8. Investment income
| Unrestricted funds 2025 £ Investment income 191,975 Bank & other interest receivable 12,748 204,723 Total 2024 178,718 |
Total funds 2025 £ 191,975 12,748 204,723 178,718 |
Total funds 2024 £ 154,344 24,374 178,718 |
|---|---|---|
Page 50
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
(A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
9. Analysis of grants
| Grants to Institutions 2025 Total funds 2025 £ £ Grants 164,262 164,262 Total 2024 376,551 376,551 The Group has made the following material grants to institutions during the year: 2025 £ Name of institution Durham University 120,000 University of Strathclyde - University of Oxford - University of Liverpool - University of Leeds 22,000 University of São Paulo 11,149 153,149 Other grants to institutions 11,113 164,262 |
Total funds 2024 £ 376,551 2024 £ - 120,000 84,000 165,000 (11,827) - 357,173 19,378 376,551 |
|---|---|
Page 51
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
(A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
10. Analysis of expenditure by activities
| Scientific Activities Total 2024 |
Activities undertaken directly 2025 £ 7,733,152 8,461,513 |
Grant funding of activities 2025 £ 164,262 376,551 |
Support costs 2025 £ 1,539,104 1,962,420 |
Total funds 2025 £ 9,436,518 10,800,484 |
Total funds 2024 £ 10,800,484 |
|---|---|---|---|---|---|
In 2025, restricted expenditure amounted to £1,128,771 (2024: £185,320) and unrestricted expenditure was £8,316,600 (2024: £10,625,126).
Analysis of direct costs
| Wages and salaries Attendance at scientific meetings Legal and other professional fees Consultants Maintenance of scientific equipment Production and distribution costs Difference on foreign exchange Staff development Total 2024 |
Activities 2025 £ 6,684,356 188,137 500 257,149 373,650 74,807 127,000 27,553 7,733,152 8,461,513 |
Total funds 2025 £ 6,684,356 188,137 500 257,149 373,650 74,807 127,000 27,553 7,733,152 8,461,513 |
Total funds 2024 £ 7,120,280 279,525 3,528 497,220 425,997 62,018 44,047 28,898 8,461,513 |
|---|---|---|---|
Page 52
(A Company Limited by Guarantee)
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
10. Analysis of expenditure by activities (continued)
Analysis of support costs
| Activities 2025 £ Staff costs 688,741 Depreciation 114,426 Consultancy - Telephone and network costs 10,575 Recruitment 22,577 Legal and other professional fees 28,551 Audit and accountancy 99,475 Banking costs 44,814 Difference on foreign exchange 157,806 Insurance 41,284 Premises costs 183,637 Bad debt expense (4,803) IT equipment, software and hardware 58,711 General expenses 46,024 Staff development 20,805 Board meeting costs 26,481 1,539,104 Total 2024 1,962,420 11. Auditor's remuneration Fees payable to the Charity's auditor for the audit of the Charity's annual accounts Fees payable to the Charity's auditor in respect of: All taxation advisory services not included above All non-audit services not included above |
Total funds 2025 £ 688,741 114,426 - 10,575 22,577 28,551 99,475 44,814 157,806 41,284 183,637 (4,803) 58,711 46,024 20,805 26,481 1,539,104 1,962,420 2025 £ 36,900 1,550 4,700 |
Total funds 2024 £ 1,075,772 115,634 51,782 14,649 44,731 76,198 87,550 42,051 27,019 40,848 150,263 17,251 47,146 47,286 89,745 34,495 1,962,420 |
|---|---|---|
| 2024 £ 32,000 1,330 5,350 |
Page 53
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
(A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
12. Staff costs
| Wages and salaries Social security costs Other pension costs |
Group 2025 £ 5,992,154 653,482 727,461 7,373,097 |
Group 2024 £ 6,663,402 723,492 809,158 8,196,052 |
Charity 2025 £ 5,629,671 624,567 701,445 6,955,683 |
Charity 2024 £ 6,002,614 628,717 758,867 7,390,198 |
|---|---|---|---|---|
In 2025, 2 redundancies and 1 termination occurred. This resulted in 3 employees receiving Payment in Lieu of Notice of £49,664.26 and 2 employees receiving termination payments of £22,526.
In 2024, a restructuring took place, resulting in 10 employees receiving Payment In Lieu Of Notice totaling £234,507. Of these 10 employees 6 also received severance payments totaling £119,782.
The average number of persons employed by the Charity during the year was as follows:
| Office and administration Technical |
Group 2025 No. 10 86 96 |
Group 2024 No. 10 99 109 |
Charity 2025 No. 9 82 91 |
Charity 2024 No. 9 92 |
|---|---|---|---|---|
| 101 |
Page 54
(A Company Limited by Guarantee)
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
12. Staff costs (continued)
The number of employees whose employee benefits (excluding employer pension costs) exceeded £60,000 was:
| Group | Group | |
|---|---|---|
| 2025 | 2024 | |
| No. | No. | |
| In the band £60,001 - £70,000 | 16 | 14 |
| In the band £70,001 - £80,000 | 6 | 8 |
| In the band £80,001 - £90,000 | 8 | 7 |
| In the band £90,001 - £100,000 | 5 | 8 |
| In the band £100,001 - £110,000 | 2 | - |
| In the band £110,001 - £120,000 | 1 | 2 |
| In the band £120,001 - £130,000 | 2 | 1 |
| In the band £150,001 - £160,000 | - | 1 |
| In the band £310,001 - £320,000 | - | 1 |
The Key Management Personnel of the charity comprise the trustees, the Executive Director and the Senior Leadership Management Team. No trustees (2024 - one) received a leaving gift worth £NIL (2024 - £221), no other trustees received any remuneration or benefits in kind from the charity (2024 - £NIL). The total employee benefits of the Key Management Personnel, including employers' NIC and employers pension of the charity were £905,643 (2024 - £1,378,666).
A total of £9,405 (2024 - £19,301) was reimbursed or paid directly to 6 (2024 - 7) trustees in respect of travel and accommodation costs.
13. Taxation
| Taxation Current tax on net income/(expenditure) for the year Taxation on net income/(expenditure) |
2025 £ 8,852 8,852 |
2024 £ 9,962 |
|---|---|---|
| 9,962 |
Page 55
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE (A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
13. Taxation (continued)
The Charity is considered to pass the tests set out in Paragraph 1 Schedule 6 of the Finance Act 2010 and therefore it meets the definition of a charitable company for UK corporation tax purposes. Accordingly, the Charity is potentially exempt from taxation in respect of income or capital gains received within categories covered by Chapter 3 Part 11 of the Corporation Tax Act 2010 or Section 256 of the Taxation of Chargeable Gains Act 1992, to the extent that such income or gains are applied exclusively to charitable purposes.
In accordance with the deed of covenant, the CCDC Services's taxable profits for the year of £423,307 (2024 - £421,153) have been distributed in favour of The Cambridge Crystallographic Data Centre. Therefore there are Nil profits on which to be taxed. CCDC Services Limited, is a wholly owned subsidiary of The Cambridge Crystallographic Data Centre. CCDC Services Limited is registered in England and Wales, company number 03483374. The registered office is 12 Union Road, Cambridge, CB2 1EZ.
The taxation of £8,852 relates soley to the CCDC Inc, a wholly owned subsidiary of The Cambridge Crystallographic Data Centre. CCDC Inc is registrered within the United States of America and the registered office is One Boston Place, Suite 2600, Boston, MA 02108.
Page 56
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
(A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
14. Tangible fixed assets
Group
| Cost or valuation At 1 January 2025 Additions Disposals At 31 December 2025 Depreciation At 1 January 2025 Charge for the year On disposals At 31 December 2025 Net book value At 31 December 2025 At 31 December 2024 |
Long-term leasehold property £ 4,508,917 23,181 - 4,532,098 2,408,348 90,487 - 2,498,835 2,033,263 2,100,569 |
Fixtures, fittings and equipment £ 727,790 - (54,720) 673,070 628,242 23,941 (54,720) 597,463 75,607 99,548 |
Total £ 5,236,707 23,181 (54,720) 5,205,168 3,036,590 114,428 (54,720) 3,096,298 2,108,870 2,200,117 |
|---|---|---|---|
Page 57
(A Company Limited by Guarantee)
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
14. Tangible fixed assets (continued)
Charity
| Cost or valuation At 1 January 2025 Additions Disposals At 31 December 2025 Depreciation At 1 January 2025 Charge for the year On disposals At 31 December 2025 Net book value At 31 December 2025 At 31 December 2024 |
Long-term leasehold property £ 4,508,917 23,181 - 4,532,098 2,408,348 90,487 - 2,498,835 2,033,263 2,100,569 |
Fixtures, fittings and equipment £ 727,790 - (54,720) 673,070 628,242 23,941 (54,720) 597,463 75,607 99,548 |
Total £ 5,236,707 23,181 (54,720) 5,205,168 3,036,590 114,428 (54,720) 3,096,298 2,108,870 2,200,117 |
|---|---|---|---|
Page 58
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
(A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
15. Fixed asset investments
| Group Cost or valuation At 1 January 2025 Additions Revaluations At 31 December 2025 Charity Cost or valuation At 1 January 2025 Additions Revaluations At 31 December 2025 |
Investments in subsidiary companies £ 163,489 - - 163,489 |
Listed investments £ 7,524,291 173,975 900,598 8,598,864 |
Listed investments £ 7,524,291 173,975 900,598 |
|---|---|---|---|
| 8,598,864 | |||
| Total £ 7,687,780 173,975 900,598 8,762,353 |
All the listed fixed asset investments are held in the UK.
All investments are carried at their fair value. Investments in equities and fixed interest securities are all traded in quoted public markets, primarily the London Stock Exchange. Holdings in common investment funds, unit trusts and open-ended investment companies are at bid price. The basis of fair value for quoted investments is equivalent to the market value, using the bid price. Asset sales and purchases are recognised at the date of trade at cost (that is their transaction value).
The Charity does not make use of derivatives and similar complex financial instruments as it takes the view that investments are held for long term growth and annual income.
The Group has no material investment holdings in markets subject to exchange controls or trading restrictions.
Page 59
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
(A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
15. Fixed asset investments (continued)
Principal subsidiaries
The following were subsidiary undertakings of the Charity:
Names Company Registered office or principal Principal activity number place of business CCDC Services Limited 03483374 12 Union Road, Cambridge, CB2 Provision of 1EZ professional services for digital drug design and manufacture, and advanced training CCDC Inc One Boston Place, Suite 2600, To provide services to Boston, MA 02108, United States the parent company, such as Education and Outreach, training, customer service and sales." Class of Holding Included in shares consolidation Ordinary 100% Yes Capital 100% Yes
The financial results of the subsidiaries for the year were:
| Names | Income | Expenditure | Profit/(Loss) | Net assets |
|---|---|---|---|---|
| £ | £ | for the year | £ | |
| £ | ||||
| CCDC Services Limited | 757,354 | (334,047) | 423,307 | 2,118 |
| CCDC Inc | 494,793 | (515,432) | (20,639) | 365,034 |
Page 60
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
(A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
16. Debtors
| Due within one year Trade debtors Amounts owed by group undertakings Other debtors Prepayments and accrued income |
Group 2025 £ 2,694,335 - 452,043 308,048 3,454,426 |
Group 2024 £ 3,115,568 - 135,150 502,112 3,752,830 |
Charity 2025 £ 2,504,371 714,393 425,167 304,554 3,948,485 |
Charity As restated 2024 £ 2,968,807 397,382 91,977 493,084 3,951,250 |
|---|---|---|---|---|
17. Creditors: Amounts falling due within one year
| Trade creditors Amounts owed to group undertakings Other taxation and social security Other creditors Accruals and deferred income Deferred income at 1 January 2025 Resources deferred during the year Amounts released from previous periods |
Group 2025 £ 54,762 - 258,084 188,749 5,062,088 5,563,683 Group 2025 £ 5,349,639 5,269,505 (5,349,639) 5,269,505 |
Group 2024 £ 38,828 - 300,965 114,221 5,172,129 5,626,143 Group 2024 £ 5,239,996 5,349,639 (5,239,996) 5,349,639 |
Charity 2025 £ 51,707 229,662 257,453 188,749 5,035,010 5,762,581 Charity 2025 £ 5,255,045 5,269,505 (5,255,045) 5,269,505 |
Charity 2024 £ 38,460 61,664 279,756 114,221 5,058,285 |
|---|---|---|---|---|
| 5,552,386 | ||||
| Charity 2024 £ 5,191,138 5,255,045 (5,191,138) |
||||
| 5,255,045 |
Deferred income relates to subscriptions received in advance of which £4,947,725 (2024: £5,079,751) relates to amounts due within 1 year and £321,780 (2024: £269,888) relates to amounts due after 1 year. Refer to note 18 for the details on amounts due after 1 year.
Page 61
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
(A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
18. Creditors: Amounts falling due after more than one year
| Other creditors Deferred income |
Group 2025 £ 414,188 321,780 735,968 |
Group 2024 £ 405,375 269,888 675,263 |
Charity 2025 £ 414,188 321,780 735,968 |
Charity 2024 £ 405,375 269,888 |
|---|---|---|---|---|
| 675,263 |
19. Prior year adjustments
For the year ended 31 December 2024, the donation from the trading subsidiary CCDC Services Limited to its parent Cambridge Crystallographic Data Centre was recognised in the consolidated financial statements but was not recognised in the individual charity financial statements and the related disclosures.
This error has resulted in an understatement of opening debtors and reserves of £421,153 in the financial statements of The Cambridge Crystallographic Data Centre.
The error has been corrected by restating the comparative information. The impact of the correction is to increase debtors and reserves by £421,153 in the comparative period.
Page 62
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
(A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
20. Statement of funds Statement of funds - current year
| Unrestricted funds Designated funds Fixed Asset Fund Research and Development Fund Sponsorship and Outreach Fund CSD and Sustainability Fund |
Balance at 1 January 2025 £ 2,200,117 173,406 65,394 100,086 2,539,003 |
Income £ - - - - - |
Expenditure £ (114,428) - (164,262) - (278,690) |
Transfers in/(out) £ 23,181 - 98,868 - 122,049 |
Gains/ (Losses) £ - - - - - |
Balance at 31 December 2025 £ 2,108,870 173,406 - 100,086 2,382,362 |
|---|---|---|---|---|---|---|
Page 63
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
(A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
20. Statement of funds (continued)
| General funds General Funds Total Unrestricted funds Restricted funds BioChem GRAPH Google Ad grant SHARPEN grant DigiCCAMMS Grant PSDI Grant DPN-MED Grant CERSI Grant Green Impact Programme Grant Total of funds |
Balance at 1 January 2025 £ 6,282,127 8,821,130 (8,054) - - - - - - - (8,054) 8,813,076 |
Income £ 9,954,949 9,954,949 - 27,071 214,529 204,163 34,331 7,491 47,743 15,000 550,328 10,505,277 |
Expenditure £ (8,188,567) (8,467,257) - (27,071) (505,438) (341,039) (34,331) (7,491) (47,743) (15,000) (978,113) (9,445,370) |
Transfers in/(out) £ (557,888) (435,839) 8,054 - 290,909 136,876 - - - - 435,839 - |
Gains/ (Losses) £ 900,598 900,598 - - - - - - - - - 900,598 |
Balance at 31 December 2025 £ 8,391,219 |
|---|---|---|---|---|---|---|
| 10,773,581 | ||||||
| - - - - - - - - - |
||||||
| 10,773,581 |
Page 64
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
(A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
20. Statement of funds (continued)
Statement of funds - prior year
| Unrestricted funds Designated funds Fixed Asset Fund Research and Development Fund Sponsorship and Outreach Fund CSD and Sustainability Fund Pension Provision Fund General funds General Funds Total Unrestricted funds |
Balance at 1 January 2024 £ 2,294,451 173,406 40,945 100,086 908,000 3,516,888 5,733,643 9,250,531 |
Income £ - - - - - - 9,759,196 9,759,196 |
Expenditure £ (115,633) - (376,551) - - (492,184) (10,132,942) (10,625,126) |
Transfers in/out £ 21,299 - 401,000 - (908,000) (485,701) 436,398 (49,303) |
Gains/ (Losses) £ - - - - - - 485,832 485,832 |
Balance at 31 December 2024 £ 2,200,117 173,406 65,394 100,086 - 2,539,003 |
|---|---|---|---|---|---|---|
| 6,282,127 | ||||||
| 8,821,130 |
Page 65
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
(A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
20. Statement of funds (continued)
| Restricted funds BioChem GRAPH ROYCE grant Google Ad grant Regulatory Network Grant SHARPEN grant Total of funds |
Balance at 1 January 2024 £ 7,406 - - - - 7,406 9,257,937 |
Income £ - 7,132 70,125 13,630 29,670 120,557 9,879,753 |
Expenditure £ (21,874) (30,241) (70,125) (13,630) (49,450) (185,320) (10,810,446) |
Transfers in/out £ 6,414 23,109 - - 19,780 49,303 - |
Gains/ (Losses) £ - - - - - - 485,832 |
Balance at 31 December 2024 £ (8,054) - - - - (8,054) 8,813,076 |
|---|---|---|---|---|---|---|
Page 66
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
(A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
20. Statement of funds (continued)
The purpose of funds above are detailed as follows:
DESIGNATED FUNDS:
Fixed Asset Fund: This fund represents the balance of the groups' reserves held as fixed assets. The transfer represents movements to fixed assets in the year.
Research and Development Fund: This fund finances research activities and makes grants for research where general funds are not available for this purpose.
Sponsorship and Outreach Fund : This fund supports the cost of funding studentships worldwide.
CSD and Sustainability Fund: This fund is established to provide support in the event of unexpected legal, legislative or regulatory events which might have a negative effect on the Centre.
RESTRICTED FUNDS:
Google Ad: CCDC receives a Google Ads Grant, as part of Google's programme to support nonprofits (https://www.google.co.uk/grants/ ). This awards us a monthly sum (max $10,000) to spend on Google advertising, which we use to promote our Access Structures service, training and learning resources, teaching materials, and events — all of which are free resources for the community. We also promote our general about us video using the grant, to raise awareness of the CCDC and our charitable activities as a whole.
BioChemGRAPH: The BioChemGRAPH project aims to establish a collaboration between PDBe, ChEMBL and CCDC to create an easily accessible resource that integrates structural, functional and biochemical annotations of small molecule data into one place. This project will promote interoperability between small molecule resources by implementing common data standards. The project also aims to improve the findability and accessibility of small molecule annotations via uniform data access mechanisms and develop intuitive web components to visualise these valuable data through web interfaces. It will significantly increase the synergies between structural and biochemical data and will lead to increased understanding of the role of small molecules in biological systems and translational research in a number of areas, including synthetic biology, target validation, and drug development. The project started on 2 November 2020 and will last 36 months. The project was extended by 12 months to 2 November 2024 due to changes in partner institute. BioChemGRAPH was funded by BBSRC, 20% of the costs will be covered by the general fund.
ROYCE: This project was an effort to augment the crystal structure data within the CSD, with calculated physical property data, of relevance to Organic Semi-Conductor (OSC) design. Following the Q4 2024 data release, researchers will be able to place the results of their own proposed OSC's, within the context of all known OSCs in the CSD; alongside understanding molecular properties such as HOMO-LUMO Gap and singlet state energies, the major barrier to widespread adoption of OSC is the tuning of crystallographic dependent properties, such as transfer integral and dynamic disorder. This project has delivered a platform for assessing proposed OSCs rapidly. The grant was funded by Henry Royce Institute. It started on 1 October 2023 with a completion date of 29 February 2024.
Regulatory network: The Regulatory Network grant was the Discovery Phase of a two phase competition to create Centres for Excellence in Regulatory Science and Innovation (CERSIs) for the UK. This grant involved building a consortium to prepare a proposal for the Implementation Phase of this competition to create a CERSI for Digital Chemistry Manufacturing and Control (CMC). This second proposal was successfully funded.
Page 67
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE (A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
20. Statement of funds (continued)
Sharpen: The SHARPEN grant intends to enable data sharing across the medicines manufacturing industry through a federated learning approach. The grant involves evolving CCDC's structural data platform to improve usability and data linking, and extending our Particle Informatics models.
DigiCCAMMS: (Digital Crystallisation Control for Advanced Medicines Manufacturing Sustainability) is a 24-month Innovate UK funded Sustainable Medicines Manufacturing Collaborative R&D project between CCDC and Durham University. The project will embed a new method to predict crystal shape into CCDC's desktop software that can take crystallisation conditions, such as solvent and supersaturation, into account. Experimental crystallisation data generated at Durham University will be used to benchmark and validate the computational tools. DigiCCAMMS runs from 1st February 2025 to 31st January 2027.
The UK Physical Sciences Data Infrastructure (PSDI): is an initiative funded by EPSRC to enable better science and innovation by building the platforms, tools and skills needed to make physical sciences data more accessible and trustworthy. The CCDC is funded as a PSDI Partner organisation. The grant will end in March 2026.
DPN-MED: (Digital Plug-and-Produce Network for Sustainable Medicines Development and Manufacturing) was a 6-month Innovate UK funded Sustainable Medicines Manufacturing Grand Challenge Expression of Interest between CCDC, the University of Strathclyde (CMAC), and the National Manufacturing Institute for Scotland (NMIS). The project sought to develop a consortium to deliver a Grand Challenge focused on automated, "plug and produce" distributed architectures for sustainable medicines manufacturing. CCDC had proposed to develop its web-based tools for predicted crystal structure data and analysis as part of the Grand Challenge. Ultimately this Expression of Interest was not successful for subsequent Grand Challenge funding. DPN-MED ran from 1st January 2025 to 30th June 2025.
The CERSI: for the Digital Transformation of Medicines Development and Manufacturing (Digital CMC CERSI) was a 14-month MHRA funded collaboration between CCDC, the University of Strathclyde (CMAC), De Montford University, and a variety of unfunded industry partners. The project sought to define a framework to enable the regulatory readiness of digital tools for pharmaceutical chemistry, manufacturing, and controls (CMC) to be assessed and developed, alongside a variety of training resources and demonstrable case studies. CCDC provided its digital solid form healthcheck as a case study alongside relevant training material. Digital CMC CERSI ran from 1st February 2025 to 31st March 2026.
Green Business Impact Programme grant: The CCDC received a £15,000 one-off capital grant through the Green Business Impact Programme, administered by Allia Impact Ltd on behalf of a consortium including Cambridge City Council and the Cambridgeshire & Peterborough Combined Authority. The funding supported the installation of solar photovoltaic panels as part of the organisation’s transition towards net zero and improved energy sustainability.
Page 68
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
(A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
21. Analysis of net assets between funds
Analysis of net assets between funds - current year
| Unrestricted funds 2025 £ Tangible fixed assets 2,108,870 Fixed asset investments 8,598,864 Current assets 6,382,581 Creditors due within one year (5,580,766) Creditors due in more than one year (735,968) Total 10,773,581 |
Total funds 2025 £ 2,108,870 8,598,864 6,382,581 (5,580,766) (735,968) 10,773,581 |
|---|---|
Analysis of net assets between funds - prior year
| Tangible fixed assets Fixed asset investments Current assets Creditors due within one year Creditors due in more than one year Total |
Unrestricted funds 2024 £ 2,200,117 7,524,291 5,398,128 (5,626,143) (675,263) 8,821,130 |
Restricted funds 2024 £ - - (8,054) - - (8,054) |
Total funds 2024 £ 2,200,117 7,524,291 5,390,074 (5,626,143) (675,263) 8,813,076 |
|---|---|---|---|
Page 69
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
(A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
22. Reconciliation of net movement in funds to net cash flow from operating activities
| Net income/expenditure for the year (as per Statement of Financial Activities) Adjustments for: Depreciation charges 14 Gain on investments 15 Dividends, interests and rents from investments 8 Decrease/(increase) in debtors 16 (Decrease)/increase in creditors 17,18 Movement in foreign exchange reserve Net cash provided by/(used in) operating activities 23. Analysis of cash and cash equivalents Cash in hand Total cash and cash equivalents 24. Analysis of changes in net debt At 1 January 2025 £ Cash at bank and in hand 1,637,244 1,637,244 |
Group 2025 £ 1,960,505 114,428 (900,598) (204,723) 298,404 (1,755) - 1,266,261 Group 2025 £ 2,911,072 2,911,072 Cash flows £ 1,273,828 1,273,828 |
Group 2024 £ (444,807) 115,634 (482,793) (178,718) (269,386) 270,462 (54) (989,662) Group 2024 £ 1,637,244 1,637,244 At 31 December 2025 £ 2,911,072 2,911,072 |
|---|---|---|
Page 70
(A Company Limited by Guarantee)
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
25. Pension commitments
The Group operates a defined benefit pension scheme.
The total pension cost for the Group for the period was £727,461 (2024 - £809,158).
Employer contributions for the year amounted to £531,034 for the Universities Superannuation Scheme and £44,415 for the Cambridge University Assistants Contributory Pension Scheme.
The Charity's employees belong to two principal pension schemes, the Universities Superannuation Scheme (USS) and the Cambridge University Assistants' Contributory Pension Scheme (CUACPS).
In 2022 the Charity added a third pension scheme, a defined contribution scheme. The assets of the scheme are held separately from those of the Group in an independently administered fund. The pension cost charge represents contributions payable by the Group to the fund.
CCDC Inc operates a defined contribution scheme. The assets of the scheme are held separately from those of the Group in an independently administered fund. The pension cost charge represents contributions payable by the Group to the fund and amounted to £26,016 (2024 - £50,291). No amounts were outstanding at the year end (2024 - £NIL).
Universities Superannuation Scheme
The charity participates in the Universities Superannuation Scheme, which is a multi-employer defined benefit pension scheme.
The scheme is a defined benefit plan in nature; however, it is not possible for the entity to identify its share of the underlying assets and liabilities of the scheme on a consistent and reasonable basis. Accordingly, in accordance with FRS 102, the scheme is accounted for as a defined contribution plan.
At the valuation date, the value of the assets of the scheme was £73.1 billion and the value of the scheme’s technical provisions was £65.7 billion indicating a surplus of £7.4 billion and a funding ratio of 111%.
The entity is therefore exposed to actuarial risks associated with the scheme, including changes in Where a deficit exists, a recovery plan has been agreed which requires participating employers to make additional contributions. The entity’s share of these deficit contributions is reflected in a provision recognised in the financial statements (where applicable).
The entity is therefore exposed to actuarial risks associated with the scheme, including changes in contribution rates arising from future valuations. These may impact the entity’s future cash flows.
No deficit recovery plan was required under the 2023 valuation because the scheme was in surplus on a technical provisions basis.
The latest available complete actuarial valuation of the the defined benefit part of the scheme, is as at 31 March 2023 (the valuation date), and was carried out using the projected unit method.
Page 71
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
(A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
25. Pension commitments (continued)
| Price inflation - Consumer Prices Index (CPI) | 3.0% pa (based on a long term average expected level of CPI, broadly consistent with long term market expectations) |
|---|---|
| RPI/CPI gap | 1.0% pa to 2030, reducing to 0.1% pa from 2030 |
| Price inflation - Retail Prices Index (RPI) | In line with the CPI assumption plus the RPI/CPI gap (i.e. 4.0% pa to 2030, reducing to 3.1% from 2030) |
| Discounts rate Pre-retirement Post-retirement |
Fixed interest gilt yield curve plus: 2.5% pa 0.9% pa |
| Pension increases (all subject to a floor of 0%) | Increases linked to CPI Benefits with no cap: CPI assumption + 3bps Benefits subject to a "soft cap" of 5% (providing inflationary increases up to 5%, and half of any excess inflation over 5% up to a maximum increase of 10%): CPI assumption - 3bps Increases capped at 2.5% (where applicable): CPI assumption-96bps |
| Mortality base table | 101% of S2PMA "light" for males and 95% of S3PFA for females |
| Future improvements to mortality | CMI_2021 with a smoothing parameter of 7.5, an initial addition of 0.4% pa, 10% w2020 and w2021 parameters, and a long term improvement rate of 1.8% pa for males and 1.6% pa for females |
Principal actuarial assumptions at the Balance Sheet date (expressed as weighted averages):
| At 31 | At 31 | |
|---|---|---|
| December | December | |
| 2025 | 2024 | |
| Years | Years | |
| Mortality rates (in years) | ||
| - for a male aged 65 now | 23.8 | 23.7 |
| - at 65 for a male aged 45 now | 25.7 | 25.6 |
| - for a female aged 65 now | 25.5 | 25.4 |
| - at 65 for a female aged 45 now | 27.2 | 27.2 |
Page 72
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
(A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
25. Pension commitments (continued)
Cambridge University Assistants' Contributory Pension Scheme
The charity participates in the Cambridge University Assistants Contributory Pension Scheme, which is a multi-employer defined benefit pension scheme.
The scheme is a defined benefit plan in nature; however, it is not possible for the entity to identify its share of the underlying assets and liabilities of the scheme on a consistent and reasonable basis. Accordingly, in accordance with FRS 102, the scheme is accounted for as a defined contribution plan. At the valuation date, the value of the assets of the scheme was £918 million and the value of the scheme’s liabilities was £880 million indicating a surplus of £38 million.
Where a deficit exists, a recovery plan has been agreed which requires participating employers to make additional contributions. The entity’s share of these deficit contributions is reflected in a provision recognised in the financial statements (where applicable).
The entity is therefore exposed to actuarial risks associated with the scheme, including changes in contribution rates arising from future valuations. These may impact the entity’s future cash flows.
No deficit recovery plan was required under the 2024 valuation because the scheme was in surplus
The latest available complete actuarial valuation of the the defined benefit part of the scheme, is as at 31 July 2024 (the valuation date), and was carried out using the projected unit method.
| Price inflation - Consumer Prices Index (CPI) | The Consumer Price Index (CPI) assumption will be determined from the RPI increase assumption less: - 1.0% per annum to 2030; -0.1% per annum from 2031 onwards |
|---|---|
| Price inflation - Retail Prices Index (RPI) | This rate will then be adjusted by an allowance for the Inflation Risk Premium, which for the purposes of the 2024 valuation the Trustee has determined should be: - 0% per annum to 2023; - 1.0% in 2031; and then - Reducing by 0.1% per annum back to 0% per annum in 2041 and thereafter |
| Discounts rate Pre-retirement Post-retirement |
Fixed interest gilt yield curve plus: 2.8% pa 2.5% pa |
| Pension increases in payment | The assumptions for future pension increases are set equal to the assumptions for RPI and CPI noted above, subject to these maxima |
| Pay increases | Pay increases are expected to exceed CPI increases by 1.5% per annum compound in the long term but an allowance has been made for pay increases of 5.7% in 2024/2025 |
Page 73
(A Company Limited by Guarantee)
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
24. Pension commitments (continued)
| Mortality base table | Male Members and Male Dependants - S4 All Pensioners Amounts table ("S4PMA"), adjusted by assuming members exhibit mortality rates at 106% of the standard table; - Female Memberrs - S4 All Pensioners Amounts table ("S4PFA"), adjusted by assuming that members exhibit mortality rates at 98% of the standard table; - Female Dependants - S4 Dependant Pensioners Amounts table ("S4DFA"), adjusted by assuming that members exhibit mortality rates at 118% of the standard table. |
|---|---|
26. Operating lease commitments
At 31 December 2025 the Group and the Charity had commitments to make future minimum lease payments under non-cancellable operating leases as follows:
| Not later than 1 year Later than 1 year and not later than 5 years |
Group 2025 £ 19,562 11,094 30,656 |
Group 2024 £ 46,246 51,003 97,249 |
Charity 2025 £ 19,562 11,094 30,656 |
Charity 2024 £ 46,246 51,003 |
|---|---|---|---|---|
| 97,249 |
During the year the group had lease payments amounting to £30,433 (2024: £47,834) relating to the EV lease scheme offered to employees.
Page 74
(A Company Limited by Guarantee)
THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
27. Related party transactions
In 2025 the following transactions took place between the Charity and its wholly owned subsidiary CCDC Services Limited:
The provision of management services by the Charity to the company of £293,279 (2024: £190,224). The transfer under deed of covenant of the trading profits of CCDC Services Limited to the Charity of £423,307 (2024: £421,153).
At the year end a balance of £714,393 (2024: £397,382) was owed to the Charity by CCDC Services Limited.
In 2025 the following transactions took place between the Charity and its wholly owned subsidiary CCDC Inc:
The provision of a sales office and related services by the company to the Charity of £494,793 (2024: £947,781).
At the year end a balance of £229,660 (2024: £61,644) was due to CCDC Inc by the Charity.
There were no other outstanding balances with related parties as at 31 December 2025 (2024 - £NIL).
Other expenses incurred by the Charity on behalf of CCDC Services amounts to £NIL (2024 - £1,182).
Other expenses incurred by CCDC Inc on behalf of the Charity amounts to £NIL (2024 - £7,745).
Suzanna Ward (Executive Director) is a Trustee of British Crystallographic Association, of which the charity is a corporate member. The memebrship fee is £850, this was at an arm's length value.
28. Post balance sheet events
As part of its focus on long term sustainability and operational efficiency, during 2026 the Centre plans to transition the employment of its US based staff to an Employer of Record model, consistent with arrangements already used elsewhere outside the UK. CCDC Inc. will remain in place, but this administrative change is expected to reduce overhead and complexity and will not impact staff, users, partners or customers in the United States.
Page 75
DocuSeal
Audit Log
Envelope ID: 1070427
Verify
CCDC 31 December 2025 for signature.pdf
Original SHA256:
CCydnkhwILvTE9JX3b5PYpeUBa3Yn1WGn-KwVw-AJCc= Result SHA256:
F1ZrRhO4BL97sSgUMMDhIhvl2kR8oWv__xBuH2FJ8QM= Generated at: 28 May, 2026 13:52 BST
susan.bourne@uct.ac.za
Email verification: Verified IP: 128.232.192.73 Session ID: a54f8d669af6a5aa7af289ea36a671de User agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64; rv:151.0) Gecko/20100101 Firefox/151.0 Time zone: Africa/Johannesburg
SIGNATURE FIELD 1, SIGNATURE FIELD 2, SIGNATURE FIELD 3
Event Log
28 May, 2026 13:19 BST
Email sent to susan.bourne@uct.ac.za
28 May, 2026 13:52 BST 28 May, 2026 13:52 BST 28 May, 2026 13:52 BST 28 May, 2026 13:52 BST
Email link clicked by susan.bourne@uct.ac.za Form viewed by susan.bourne@uct.ac.za
Submission started by susan.bourne@uct.ac.za Submission completed by susan.bourne@uct.ac.za